id est avocats advised Lymphatica Medtech in their Series A financing round
Lymphatica Medtech, a vascular medical device development start-up, closes their financing round to advance clinical validation aiming at revolutionizing the treatment of chronic lymphedema. The investment round was led by High-Tech Gründerfonds (HTGF), EIT health (European Institute of Innovation and Technology), business angels, and existing investor LIVEventures.